and antibody engineering), plasmid and lentiviral vector process development for cell therapy, clinical plasmid production (such as gene therapy plasmid and cell therapy plasmid), GMP lentiviral ...

This issue highlights a high-throughput method for the rapid discovery of high-affinity antibodies ... in viral processes can constrain the lentiviral delivery and expression of Cas13, and ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...